ZA200001010B - Microdisperse drug delivery systems. - Google Patents

Microdisperse drug delivery systems.

Info

Publication number
ZA200001010B
ZA200001010B ZA200001010A ZA200001010A ZA200001010B ZA 200001010 B ZA200001010 B ZA 200001010B ZA 200001010 A ZA200001010 A ZA 200001010A ZA 200001010 A ZA200001010 A ZA 200001010A ZA 200001010 B ZA200001010 B ZA 200001010B
Authority
ZA
South Africa
Prior art keywords
microdisperse
drug delivery
delivery systems
systems
drug
Prior art date
Application number
ZA200001010A
Inventor
Siva Narayan Tallavajhala
Original Assignee
Em Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Em Ind Inc filed Critical Em Ind Inc
Publication of ZA200001010B publication Critical patent/ZA200001010B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
ZA200001010A 1998-07-14 2000-02-29 Microdisperse drug delivery systems. ZA200001010B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9276798P 1998-07-14 1998-07-14

Publications (1)

Publication Number Publication Date
ZA200001010B true ZA200001010B (en) 2000-10-16

Family

ID=22235064

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200001010A ZA200001010B (en) 1998-07-14 2000-02-29 Microdisperse drug delivery systems.

Country Status (8)

Country Link
EP (1) EP1015046A2 (en)
JP (1) JP2002520377A (en)
CN (1) CN1273526A (en)
AU (1) AU4989299A (en)
CA (1) CA2302735A1 (en)
DE (1) DE1015046T1 (en)
WO (1) WO2000003753A2 (en)
ZA (1) ZA200001010B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1337273A2 (en) 2000-11-28 2003-08-27 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
AU2002357012A1 (en) * 2001-11-27 2003-06-10 Transform Pharmaceuticals, Inc. Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
FR2833842B1 (en) * 2001-12-21 2004-02-13 Aventis Pharma Sa PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES
EP1498143A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
EP1498122A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid systems containing azetidine derivatives
BRPI0418427A (en) * 2004-01-30 2007-06-12 Pfizer Italia Srl semi-solid matrix pharmaceutical formulations
US7345093B2 (en) 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US7659310B2 (en) 2004-04-27 2010-02-09 Formatech, Inc. Methods of enhancing solubility of agents
FR2873585B1 (en) * 2004-07-27 2006-11-17 Aventis Pharma Sa NEW GALENIC FORMULATIONS OF ACTIVE PRINCIPLES
GB2451811A (en) 2007-08-09 2009-02-18 Ems Sa Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
CL2008003092A1 (en) * 2007-10-19 2009-11-27 Abbott Gmbh & Co Kg Solid dispersion product comprising an active agent derived from n-aryl urea, a matrix-forming agent selected from cyclodextrins, polymers, lipids and a non-ionic surfactant; process for preparing said dispersion product; and a pharmaceutical dosage form comprising it.
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
US8591942B2 (en) 2009-09-23 2013-11-26 Indu JAVERI Methods for the preparation of liposomes comprising docetaxel
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
JP2020503269A (en) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド Oral testosterone undecanoate therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565188A (en) * 1995-02-24 1996-10-15 Nanosystems L.L.C. Polyalkylene block copolymers as surface modifiers for nanoparticles

Also Published As

Publication number Publication date
WO2000003753A3 (en) 2000-05-04
AU4989299A (en) 2000-02-07
DE1015046T1 (en) 2001-02-08
WO2000003753A2 (en) 2000-01-27
JP2002520377A (en) 2002-07-09
CN1273526A (en) 2000-11-15
CA2302735A1 (en) 2000-01-27
EP1015046A2 (en) 2000-07-05

Similar Documents

Publication Publication Date Title
HK1036230A1 (en) Drug delivery devices.
ZA200001010B (en) Microdisperse drug delivery systems.
EP1080231A4 (en) Multimolecular devices, drug delivery systems and single-molecule selection
HK1048427A1 (en) Drug delivery device.
ZA200107123B (en) Oral drug delivery system.
HUP0300246A3 (en) Delivery system
EP1104286A4 (en) Composite hydrogel drug delivery systems
AU1618800A (en) Microporous drug delivery system
EP1061987A4 (en) Drug delivery system
EP1098673A4 (en) Agent delivery systems
ZA99283B (en) Inhaler for medication.
ZA97976B (en) Uniform drug delivery theraphy.
EP0989878A4 (en) Drug delivery system
ZA200203707B (en) Pharmaceutical combinations.
ZA200000610B (en) Micro-osmotic controlled drug delivery systems.
GB9809933D0 (en) Drug delivery device
AU2367900A (en) Chewable drug delivery system
EP1021137A4 (en) Drug delivery system
GB9811691D0 (en) Flavour delivery systems
GB2352314B (en) Delivery system
GB0011066D0 (en) Delivery system
GB0029843D0 (en) Drug delivery system
ZA974920B (en) Drug delivery systems.
GB9800835D0 (en) Drug delivery system
GB2337520B (en) Delivery system